Skip to content

Biodesix, Inc. BDSX Shares (Diluted)

Shares (Diluted) at other companies

NeoGenomics logo
NeoGenomicsNEO
129.2M+1.4%
Veracyte logo
VeracyteVCYT
81.3M+1.6%
Adaptive Biotechnologies logo
Adaptive BiotechnologiesADPT
155.5M+4.2%
Personalis, Inc. logo
Personalis, Inc.PSNL
104.2M+19.1%
Guardant Health logo
Guardant HealthGH
131.3M+6.0%
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
179M+5.0%

Other financials

Income statement

See full
Revenue$25.6M+42.3%
Operating income-$6.2M+32.1%
Net income-$7.8M+29.8%
EPS (diluted)-$0.81+46.7%

Balance sheet

See full
Cash & equivalents$25.6M+45.3%
Total debt$71.6M+15.0%
Total equity$9.1M-17.4%
Total assets$94.6M+9.7%

Cash flow

See full
Operating cash flow-$10.2M-18.2%
CapEx$81.0K+9.5%
Free cash flow-$10.2M-18.1%

Valuation

See full
Market cap$233.52M+476%
Enterprise value$279.56M+204%
P/S2.4×+1.9×

Profitability

See full
Operating margin-26%-7.5pp
Net margin-33.3%-9.3pp
FCF margin-26.8%-9.6pp

Returns & leverage

See full
Return on equity-316.5%
Debt / equity7.8×+2.2×
Current ratio2.8×+0.6×

Where this comes from

Reported directly by Biodesix, Inc. in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The official record: Biodesix, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biodesix, Inc.'s shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biodesix, Inc.'s shares (diluted)?
Biodesix, Inc. (BDSX) reported shares (diluted) of 9.7M in Q1 2026.
How has Biodesix, Inc.'s shares (diluted) changed year-over-year?
Biodesix, Inc.'s shares (diluted) increased by 32.3% year-over-year, from 7.3M to 9.7M.
What is the long-term trend for Biodesix, Inc.'s shares (diluted)?
Over 4 years (2021 to 2025), Biodesix, Inc.'s shares (diluted) has grown at a 18.9% compound annual growth rate (CAGR), from 84.5M to 169M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.